Literature DB >> 20555303

Leflunomide: a small step forward in meeting the urgent need for treatment of drug-resistant cytomegalovirus infection.

David R Snydman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555303     DOI: 10.1097/TP.0b013e3181e8a6c9

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

Authors:  Thomas Goldner; Guy Hewlett; Nicole Ettischer; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  The effects of leflunomide on CD4(+)CD25 (+)Foxp3 (+) T regulatory cells in mice receiving allogeneic bone marrow transplantation.

Authors:  Di Jin; Kaizhong Duan; Lianjun Zhang; Jianxia Peng; Yong Zhao
Journal:  Inflamm Res       Date:  2011-11-05       Impact factor: 4.575

3.  Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients.

Authors:  Tracy L Lemonovich; Richard R Watkins
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 4.  In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Samira Karami; Elham Roshandel; Haniyeh Ghaffari Nazari; Abbas Hajifathali; Farzaneh Tavakoli; Sayeh Parkhideh
Journal:  Virusdisease       Date:  2021-07-28

5.  Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus.

Authors:  Ren Qi; Zeng Hua-Song; Zeng Xiao-Feng
Journal:  Eur J Med Res       Date:  2013-02-01       Impact factor: 2.175

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.